Stock Taper 
EXOME ASSET MANAGEMENT LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Boston Scientific Corporation | BSX | 48.35K | $2.06M |
 Viking Therapeutics, Inc. | VKTX | 47.86K | $1.87M |
 Relay Therapeutics, Inc. | RLAY | 47.53K | $889.3K |
 Abivax S.A. | ABVX | 46.88K | $6.25M |
 Replimune Group, Inc. | REPL | 40.36K | $446.8K |
 Liquidia Corporation | LQDA | 39.22K | $3.13M |
 Arrowhead Pharmaceuticals, Inc. | ARWR | 32.21K | $2.63M |
 Rhythm Pharmaceuticals, Inc. | RYTM | 32.21K | $3.58M |
 Praxis Precision Medicines, Inc. | PRAX | 27.2K | $9.11M |
 Nektar Therapeutics | NKTR | 22.42K | $1.56M |
 Glaukos Corporation | GKOS | 19.86K | $2.78M |
 BridgeBio Pharma, Inc. | BBIO | 18.36K | $1.37M |
 Insmed Incorporated | INSM | 13.87K | $1.48M |
 Natera, Inc. | NTRA | 13.8K | $3.75M |
 Establishment Labs Holdings Inc. | ESTA | 13.1K | $1.12M |
 AstraZeneca PLC | AZN | 12.04K | $2.25M |
 UnitedHealth Group Incorporated | UNH | 9.61K | $4M |
 Ascendis Pharma A/S | ASND | 6.57K | $1.75M |
 Penumbra, Inc. | PEN | 6.3K | $1.99M |
 Eli Lilly and Company | LLY | 5.49K | $6.59M |